## Most Common Enzyme Inhibition Type **Key Point:** Competitive inhibition is the most frequently observed and clinically relevant form of enzyme inhibition in both pharmacology and biochemistry. ### Why Competitive Inhibition Dominates Competitive inhibitors are the most common because they: 1. Reversibly bind to the enzyme's active site 2. Can be overcome by increasing substrate concentration 3. Form the basis of most rational drug design 4. Are easily reversible and physiologically manageable ### Clinical and Pharmacological Significance | Inhibition Type | Frequency | Reversibility | Overcome by ↑[S] | Clinical Examples | |---|---|---|---|---| | **Competitive** | **Most common** | **Reversible** | **Yes** | Statins (HMG-CoA inhibitors), ACE inhibitors, NSAIDs | | Non-competitive | Less common | Reversible | No | Some antibiotics, certain toxins | | Uncompetitive | Rare | Reversible | No | Levodopa metabolism, some anticonvulsants | | Allosteric | Moderate | Reversible | Variable | Phosphofructokinase regulation, hemoglobin cooperativity | **High-Yield:** The vast majority of FDA-approved drugs work via competitive inhibition because this mechanism allows for dose-dependent efficacy and safety margins. ### Kinetic Characteristics of Competitive Inhibition **Key Point:** In competitive inhibition: - Vmax remains unchanged - Km increases (apparent Km = Km(1 + [I]/Ki)) - Lineweaver-Burk plot shows x-intercept shift - Inhibition is reversible and substrate-concentration dependent **Mnemonic:** **COVI** = Competitive Overcomes Via Increased substrate ### Why Other Types Are Less Common - **Non-competitive inhibition:** Requires binding to a site other than the active site; less predictable - **Uncompetitive inhibition:** Binds only to enzyme-substrate complex; rare in nature - **Allosteric inhibition:** Important for regulation but less common as a primary inhibitory mechanism in drug design **Clinical Pearl:** Most therapeutic drugs are competitive inhibitors because they can be titrated based on substrate (e.g., cholesterol for statins, angiotensin II for ACE inhibitors) and have predictable pharmacokinetics.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.